<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">CD19 and BAFF-R can signal to promote B-cell survival in the absence of Syk</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-01-28">28 January 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Elias</forename><surname>Hobeika</surname></persName>
							<email>hobeika@ie-freiburg.mpg.de</email>
							<affiliation key="aff0">
								<orgName type="department">Max-Planck Institute of Immunobiology and Epigenetics</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Molecular Immunology</orgName>
								<orgName type="department" key="dep2">Faculty of Biology</orgName>
								<orgName type="institution">Albert-Ludwigs-Universität Freiburg</orgName>
								<address>
									<settlement>BioIII, Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ella</forename><surname>Levit-Zerdoun</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Max-Planck Institute of Immunobiology and Epigenetics</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Vasiliki</forename><surname>Anastasopoulou</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Immunology</orgName>
								<orgName type="institution">Charité Campus Buch</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Roland</forename><surname>Pohlmeyer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Max-Planck Institute of Immunobiology and Epigenetics</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simon</forename><surname>Altmeier</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Mircobiology</orgName>
								<orgName type="institution" key="instit1">Swiss Federal Institute of Technology</orgName>
								<orgName type="institution" key="instit2">ETH Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ameera</forename><surname>Alsadeq</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of General Pediatrics</orgName>
								<orgName type="institution">University Medical Center Schleswig-Holstein</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marc-Werner</forename><surname>Dobenecker</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Laboratory of Immune Cell Epigenetics and Signaling</orgName>
								<orgName type="institution">The Rockefeller University</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Roberta</forename><surname>Pelanda</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Immunology and Microbiology</orgName>
								<orgName type="institution">University of Colorado School of Medicine</orgName>
								<address>
									<settlement>Aurora</settlement>
									<region>CO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Reth</surname></persName>
							<email>michael.reth@bioss.uni-freiburg.de</email>
							<affiliation key="aff0">
								<orgName type="department">Max-Planck Institute of Immunobiology and Epigenetics</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Molecular Immunology</orgName>
								<orgName type="department" key="dep2">Faculty of Biology</orgName>
								<orgName type="institution">Albert-Ludwigs-Universität Freiburg</orgName>
								<address>
									<settlement>BioIII, Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Centre For Biological Signaling Studies</orgName>
								<orgName type="institution" key="instit1">BIOSS</orgName>
								<orgName type="institution" key="instit2">University of Freiburg</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Königsberger</surname></persName>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Kiefer</surname></persName>
						</author>
						<title level="a" type="main">CD19 and BAFF-R can signal to promote B-cell survival in the absence of Syk</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-01-28">28 January 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">1F896F353C8C9B286207FEF55A75037A</idno>
					<idno type="DOI">10.15252/embj.201489732</idno>
					<note type="submission">Received 6 August 2014 | Revised 23 December 2014 | Accepted 2 January 2015 |</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:24+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>BAFF receptor</term>
					<term>B-cell antigen receptor</term>
					<term>CD19</term>
					<term>mb1-CreER T2</term>
					<term>Syk Subject Categories Immunology</term>
					<term>Signal Transduction</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The development and function of B lymphocytes is regulated by numerous signaling pathways, some emanating from the B-cell antigen receptor (BCR).</s><s>The spleen tyrosine kinase (Syk) plays a central role in the activation of the BCR, but less is known about its contribution to the survival and maintenance of mature B cells.</s><s>We generated mice with an inducible and B-cell-specific deletion of the Syk gene and found that a considerable fraction of mature Syk-negative B cells can survive in the periphery for an extended time.</s><s>Syk-negative B cells are defective in BCR, RP105 and CD38 signaling but still respond to an IL-4, anti-CD40, CpG or LPS stimulus.</s><s>Our in vivo experiments show that Syk-deficient B cells require BAFF receptor and CD19/PI3K signaling for their long-term survival.</s><s>These studies also shed a new light on the signals regulating the maintenance of the normal mature murine B-cell pool.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>B lymphocytes play an essential role in the establishment of humoral immunity.</s><s>Their production and maintenance requires the expression of a functional BCR, as well as signals from the B-cell environment <ref type="bibr" target="#b13">(Dorshkind, 1990;</ref><ref type="bibr" target="#b32">Lam et al, 1997)</ref>.</s><s>In the adult mouse, B-cell development occurs first in the bone marrow (BM) in the presence of the chemokine CXCL12 and interleukin IL-7 <ref type="bibr" target="#b18">(Grabstein et al, 1993;</ref><ref type="bibr" target="#b42">Nagasawa, 2007)</ref>.</s><s>The expression of a pre-BCR on the surface of B-cell precursors marks the transition from the pro-to the pre-B-cell stage <ref type="bibr" target="#b18">(Grabstein et al, 1993;</ref><ref type="bibr" target="#b46">Pelanda et al, 2002a)</ref>.</s><s>The pre-BCR is an autonomously active receptor, signals of which drive clonal expansion and differentiation of pre-B cells into immature, BCR-expressing B cells <ref type="bibr" target="#b31">(Kohler et al, 2008;</ref><ref type="bibr" target="#b23">Herzog et al, 2009)</ref>.</s><s>This signaling requires the interaction of the pre-BCR with the kinase Syk <ref type="bibr" target="#b9">(Cheng et al, 1995;</ref><ref type="bibr" target="#b50">Reth &amp; Nielsen, 2014)</ref>.</s><s>Therefore, B cells with defective genes for Syk or any of the four pre-BCR components have a complete or partial block in development <ref type="bibr" target="#b59">(Turner et al, 1997;</ref><ref type="bibr" target="#b43">Otipoby et al, 2001;</ref><ref type="bibr" target="#b63">Yang &amp; Reth, 2010)</ref>.</s></p><p><s>Immature B cells migrate from the BM to the spleen, where they develop further through transitional B-cell stages into either marginal zone (MZ) or mature follicular B cells.</s><s>In addition to mature B cells, the peritoneum of the mouse also harbors B1 B cells that are polyreactive and seem to require continuous BCR expression and stimulation for their survival <ref type="bibr" target="#b20">(Hayakawa et al, 1985;</ref><ref type="bibr" target="#b56">Sindhava &amp; Bondada, 2012)</ref>.</s><s>Therefore, the deletion of genes encoding components of the BCR signaling pathway frequently results in the loss of this B-cell type.</s><s>In its monomeric form, the BCR is a 1:1 complex between the membrane-bound immunoglobulin molecule (mIg) and the Iga/Igb heterodimer.</s><s>On resting mature B cells, the BCR forms autoinhibited oligomers which prevent continuous signaling <ref type="bibr" target="#b63">(Yang &amp; Reth, 2010)</ref>.</s><s>Upon exposure to cognate antigens, some BCR oligomers are opened and phosphorylated on tyrosines in the immunoreceptor tyrosine-based activation motif (ITAM) of Iga and Igb by the tyrosine kinases Lyn and Syk <ref type="bibr" target="#b49">(Reth, 1989;</ref><ref type="bibr" target="#b29">Johnson et al, 1995)</ref>.</s><s>This results in the binding of Syk to the BCR via its tandem SH2 domains, the rapid phosphorylation of neighboring BCR oligomers and the amplification of the BCR signal via a Sykmediated inside-out signaling process <ref type="bibr" target="#b30">(Klasener et al, 2014)</ref>.</s></p><p><s>Once bound to the BCR, Syk becomes fully activated and phosphorylates several downstream signaling elements, including the adaptor protein SLP65/BLNK.</s><s>This organizes the calcium (Ca 2+ ) signalosome, leading to Ca 2+ mobilization and activation of the MAP kinase pathway <ref type="bibr" target="#b29">(Johnson et al, 1995;</ref><ref type="bibr" target="#b51">Sada et al, 2001;</ref><ref type="bibr" target="#b62">Xu et al, 2005)</ref>.</s><s>Syk can also phosphorylate the inhibitory receptor CD22, whereas the BCR coreceptor CD19 is dominantly phosphorylated in a Syk-independent manner by Src-family kinases including Lyn <ref type="bibr" target="#b17">(Fujimoto et al, 2000;</ref><ref type="bibr" target="#b43">Otipoby et al, 2001;</ref><ref type="bibr" target="#b61">Xu et al, 2002)</ref>.</s><s>Phosphorylated CD19 is associated with and activates several signaling components, most prominently the p85/p110 PI3K heterodimer.</s><s>Therefore, together with the adaptor protein BCAP, CD19 is the dominant activator of the PI3K pathway leading to B-cell survival and proliferation <ref type="bibr" target="#b5">(Brunet et al, 1999;</ref><ref type="bibr" target="#b11">Datta et al, 1999;</ref><ref type="bibr" target="#b41">Monroe, 2006;</ref><ref type="bibr" target="#b0">Aiba et al, 2008;</ref><ref type="bibr" target="#b57">Srinivasan et al, 2009)</ref>.</s></p><p><s>The B-cell-activating factor belonging to the TNF family (BAFF) and its receptor BAFF-R provide another important survival signal in mature B cells <ref type="bibr" target="#b38">(Mackay et al, 2010;</ref><ref type="bibr" target="#b19">Harless et al, 2001)</ref>.</s><s>Both PI3K and BAFF-R signals regulate the homeostasis of mature B cells.</s><s>Mice deficient for BAFF or BAFF-R have reduced follicular and MZ B-cell numbers, and the same holds true for defects in PI3K <ref type="bibr" target="#b53">(Sasaki et al, 2004;</ref><ref type="bibr" target="#b14">Durand et al, 2009)</ref>.</s><s>Another factor implicated in the survival of mature B cells is the BCR itself.</s><s>Indeed, the lack of the mIgM heavy chain in mature B cells results in the loss of BCR expression and a strong reduction in mature B-cell numbers <ref type="bibr" target="#b32">(Lam et al, 1997)</ref>.</s><s>Whether this is due to the absence of a tonic pro-survival signaling or the induction of a death signal in mIgM-negative B cells is not yet clear.</s><s>A tonic BCR signal may employ different signaling components than those involved in B-cell activation or it may use the standard BCR signaling components at reducedlevels <ref type="bibr" target="#b41">(Monroe, 2006)</ref>.</s><s>Of interest in this context is the recent finding that the deletion of the Syk gene in all hematopoietic cells of the mouse also results in strongly reduced B-cell numbers <ref type="bibr" target="#b55">(Schweighoffer et al, 2013)</ref>.</s><s>Based on the finding that the Syk-negative B cells respond less well to BAFF in culture, the authors suggest that Syk is an essential intermediate between the BAFF-R and the tonic signal of the BCR.</s><s>We have revisited this issue in a mouse strain, which permits an inducible deletion of the Syk gene specifically in the B-cell lineage.</s><s>We find that up to 25% of Syk-negative B cells survive for long time periods in the periphery of these mice.</s><s>While the study by Schweighoffer et al focuses on the death of B cells in the absence of Syk, we have examined Syk-independent survival signals in B cells.</s><s>We find that in the absence of Syk, B cells are still able to respond to BAFF and depend on its presence for their survival.</s><s>Thus, Syk is not required for the B-cell response to BAFF.</s><s>Furthermore, survival of Syk-deficient B cells requires CD19 and its activation of the PI3K pathway as Syk-deficient B cells do not survive in the absence of CD19 and survive better when they lack FoxO1.</s><s>In summary, both the BAFF and CD19-PI3K pathways provide important signals for the survival of B cells in the absence of Syk.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Efficient, inducible deletion of the Syk gene in B cells of mb1-CreER T2 ;Syk fl/fl mice To investigate the function of genes in mature B cells, we generated the mouse line mb1-CreER T2 allowing for an inducible and B-cellspecific Cre activity.</s><s>We inserted a cDNA encoding the CreER T2 recombinase into the mb-1 gene, which is primarily expressed in B cells.</s><s>The CreER T2 construct, a gift from P. Chambon, encodes a fusion protein consisting of the Cre recombinase and a mutated ligand-binding domain of the estrogen receptor (ER), which binds the estrogen analog tamoxifen (Tam) but not estrogen itself <ref type="bibr" target="#b4">(Brocard et al, 1998;</ref><ref type="bibr" target="#b26">Indra et al, 1999)</ref>.</s><s>The mb1-CreER T2 allele contains the promoter region of the mb-1 gene followed by exon I with a mutated start codon, the complete intron I, the CreER T2 cDNA inserted into exon II behind a newly generated start codon and an SV40 polyA signal <ref type="bibr">(Fig 1A)</ref>.</s><s>We have previously demonstrated that an mb1-Cre allele generated by the same strategy can drive B-cellrestricted Cre expression and deletion of floxed genes at all B-cell developmental stages (except plasma cells) starting from the pro/ pre-B-cell stage <ref type="bibr" target="#b24">(Hobeika et al, 2006;</ref><ref type="bibr" target="#b36">Liu et al, 2007)</ref>.</s><s>We found that mb1-CreER T2 mice expressed CreER T2 only in cells of the B-cell lineage and that the protein was localized to the nucleus when cells were exposed to Tam (data not shown).</s></p><p><s>To investigate the role of Syk in the activation and survival of mature B cells, we crossed mb1-CreER T2 mice with Syk fl/fl mice, in which the exon I of the Syk gene is flanked by cis-orientated loxP sites (floxed) <ref type="bibr" target="#b52">(Saijo et al, 2003)</ref>.</s><s>The resulting mb1-CreER T2 ;Syk fl/fl mice were treated 5× with Tam every third day and analyzed on day 5 after the last treatment, 20 days after the beginning of the treatment.</s><s>Splenic B cells isolated from the Tam-treated mice lacked both Syk transcripts and protein as demonstrated by a RT-PCR and a Western blot analysis <ref type="bibr">(Fig 1B and C)</ref>.</s><s>Additionally, flow cytometric analysis revealed that lymph node (LN)-derived mature B cells from Tam-treated mb1-CreER T2 ;Syk fl/fl mice were devoid of intracellular Syk expression, in contrast to LN-derived B cells from mb1-CreER T2 control mice which also received Tam <ref type="bibr">(Fig 1D)</ref>.</s><s>The efficient deletion of the floxed Syk allele in Tam-treated mb1-CreER T2 ;Syk fl/fl mice was further confirmed by PCR analysis of genomic DNA <ref type="bibr">(Fig 1E)</ref>.</s><s>Notably, the floxed Syk gene is the most efficient Cre target we have studied, indicating that in B cells this gene locus is highly accessible to the Cre recombinase.</s></p><p><s>The B-cell populations of Tam-treated mb1-CreER T2 ;Syk fl/fl mice Five days after the last Tam treatment, the frequencies and absolute cell numbers of pro-/pre-and immature B cells in the BM did not differ significantly between mb1-CreER T2 control and mb1-CreER T2 ;Syk fl/fl mice while recirculating B cells were slightly reduced (Fig <ref type="figure" target="#fig_3">2A and C</ref>).</s><s>In the spleen (SP) of Tam-treated mb1-CreER T2 ;Syk fl/fl mice, however, the relative and absolute numbers of mature follicular (M) and marginal zone (MZ) B cells were reduced threefold and tenfold, respectively <ref type="bibr">(Fig 2B and D)</ref>.</s><s>In other lymphatic organs such as the peritoneal cavity (PC), the B1 cell numbers were also reduced in the Tam-treated mb1-CreER T2 ; Syk fl/fl mice (Fig <ref type="figure" target="#fig_3">2E</ref>).</s><s>B1 B cells proliferate constitutively, and this might contribute to a selection against Syk-negative B cells.</s><s>We tested this by intracellular Syk staining in flow cytometric analysis and found that all B1 B cells in the PC of mb1-CreER T2 ;Syk fl/fl mice were Syk negative <ref type="bibr">(Supplementary Fig S1)</ref>.</s><s>Interestingly, the transitional B-cell numbers in the spleen of the Tam-treated mice were not altered <ref type="bibr">(Fig 2B)</ref>, suggesting that this transitional B-cell pool is rapidly replenished with Syk-sufficient transitional B cells after the discontinuation of the Tam treatment.</s><s>This notion is supported by a intracellular flow cytometric analysis of transitional and immature B cells in the BM of Tam-treated mb1-CreER T2 ;</s></p><p><s>The A partial signaling defect in Syk-deficient mature B cells</s></p><p><s>The presence of a pool of Syk-negative B cells in the spleen of Tamtreated mb1-CreER T2 ;Syk fl/fl mice allowed us to study the signaling behavior of mature B cell in the absence of Syk.</s><s>We first analyzed the expression of the BCR and coreceptors on the surface of splenic B cells derived from Tam-treated mb1-CreER T2 control and mb1-CreER T2 ;Syk fl/fl mice.</s><s>In comparison with the control B cells, the Syk-negative B cells displayed slightly increased amounts of IgM, CD19 and CD23 on their surface (Fig <ref type="figure" target="#fig_4">3A</ref>) even though the Syknegative B cells were smaller than control B cells (data not shown).</s></p><p><s>Exposure of mature B cells to the phosphatase inhibitor pervanadate results in increased tyrosine phosphorylation (pY) <ref type="bibr" target="#b60">(Wienands et al, 1996)</ref>.</s><s>We treated splenic B cells with pervanadate for 5 min and determined the intracellular pY levels by flow cytometry.</s><s>In comparison with control B cells, the Syk-deficient B cells showed eightfold lower pY <ref type="bibr">(Fig 3B)</ref>.</s><s>To test whether Syk-deficient B cells could mobilize intracellular Ca 2+ upon BCR engagement, we stimulated isolated splenic B cells from Tam-treated mb1-CreER T2 control and mb1-CreER T2 ;Syk fl/fl mice with an anti-kappa F(ab 0 ) 2 antibody.</s><s>Only the control B cells, but not the Syk-negative B cells, mobilized A Schematic representation of the targeted mb-1 locus harboring the CreER T2 construct and the "floxed" Syk locus.</s><s>The construct is inserted between exons I and IV.</s><s>The filled rectangles represent the exons of the mb-1 allele.</s><s>The open rectangle represents the CreER T2 construct followed by a poly-adenylation (pA) site.</s><s>The black circle represents the endogenous pA site of the mb-1 allele.</s><s>The "truncated" version of mb-1 exon I shown here lacks the ATG start codon and is followed by the complete mb-1 intron I with its splice donor and acceptor sites.</s><s>Intron I was maintained to provide intron/exon splicing in the transcript and as a source of possible transcription regulatory sequences.</s><s>The targeted Syk locus was targeted with 2 LoxP sites and has been described in <ref type="bibr" target="#b52">Saijo et al (2003)</ref>.</s><s>B RT-PCR performed on cDNA from RNA isolated from splenic B cells derived from Tam-treated mb1-CreER T2 (left lane) or mb1-CreER T2 ;Syk fl/fl mice (right lane); the Sykand Hprt-specific amplification products were identified by agarose gel electrophoresis with Hprt used as an endogenous loading control.</s><s>C Immunoblot analysis of proteins isolated from B cells derived from spleens of mb1-CreER T2 (left lane) or mb1-CreER T2 ;Syk fl/fl (right lane) mice both treated with Tam as described; blots were probed with anti-Syk and anti-GAPDH Ab, GAPDH being used as a loading control.</s><s>D Intracellular flow cytometric analysis for Syk expression in B cells derived from the LN of Syk-deficient and control mice.</s><s>E Genomic DNA analysis of Tam-treated mb1-CreER T2 or mb1-CreER T2 ;Syk fl/fl mice (as indicated).</s><s>Ca 2+ upon treatment with this stimulus (Fig 3C  <ref type="bibr" target="#b58">(Takata et al, 1994)</ref>.</s></p><p><s>As another readout for BCR-dependent or BCR-independent B-cell signaling, we analyzed mTOR activation and the chemotactic B-cell activation increases the expression of CD86 on the surface of stimulated mature B cells <ref type="bibr" target="#b33">(Lenschow et al, 1993)</ref>.</s><s>We exposed B cells from Tam-treated mb1-CreER T2 control or mb1-CreER T2 ;Syk fl/fl mice to different stimuli and monitored their CD86 expression by flow cytometry.</s><s>Contrary to control B cells, the Syk-negative B cells failed to upregulate CD86 when stimulated with anti-IgM F(ab 0 ) 2 , anti-CD38 and anti-RP105, indicating that direct and indirect signaling via the BCR is defective in the absence of <ref type="bibr">Syk (Fig 4A)</ref>.</s><s>Increased CD86 expression was, however, detected when Syknegative B cells were stimulated with anti-CD40, IL-4, CpG, and to a A Flow cytometric analysis of IgM, CD19 and CD23 expression of splenic B cells from Tam-treated mb1-CreER T2 control (dashed line) and mb1-CreER T2 ;Syk fl/fl mice (solid line).</s><s>B Flow cytometric analysis of tyrosine phosphorylation (pY) in splenic B cells from Tam-treated mb1-CreER T2 and mb1-CreER T2 ;Syk fl/fl mice stimulated with medium (dotted line) or 50 lM pervanadate (dashed and solid lines).</s><s>C, D Flow cytometric analysis of the intracellular Ca 2+ influx in purified splenic B cells derived from Tam-treated mice.</s><s>mb1-CreER T2 or mb1-CreER T2 ;Syk fl/fl were treated with (C) 10 lg/ml anti-Kappa F(ab 0 ) 2 fragments or (D) 1 lM ionomycin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A fraction of Syk-negative B cells can survive for extended times in vivo</head><p><s>The partial loss of mature B cells in Tam-treated mb1-CreER T2 ;Syk fl/fl mice could be due to increased death of Syk-negative mature B cells and/or to a reduced input into the mature B-cell compartment.</s><s>To distinguish between these possibilities, we injected Rag2 À/À ;c c À/À mice, which cannot produce B or T cells, with equal numbers of mature splenic T or B cells from either mb1-CreER T2 or mb1-CreER T2 ;Syk fl/fl mice.</s><s>The recipient mice were then treated a total of 5 times with Tam at 3-day intervals, and T-or B-cell cellularity was monitored 20 days later by flow cytometry <ref type="bibr">(Fig 5A)</ref>.</s><s>While the number of T cells from mb1-CreER T2 ;Syk fl/fl mice was not altered by the Tam treatment, compared to the control, the number of mature B cells derived from the mb1-CreER T2 ;Syk fl/fl mice was reduced by approximately threefold (Fig <ref type="figure">5B</ref>).</s><s>Similar results were obtained from mice, which were injected after the last Tam treatment with anti-IL-7 receptor antibodies to block the migration of newly generated B cells from the bone marrow.</s><s>In these mice, more than 40% of the mature splenic B cells survived without Syk for more than 40 days (Supplementary Fig S7 <ref type="figure">),</ref> showing again that a considerable fraction of mature B cells can survive without Syk.</s></p><p><s>To study the survival of Syk-negative B cells in the presence of wild-type (WT) B cells, we injected Rag2 À/À ;c c À/À mice with equal 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 medium</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Syk-negative B cells require BAFF for their survival</head><p><s>To test whether Syk-negative B cells can respond to the pro-survival factor BAFF, we cultured B cells from Tam-induced mb1-CreER T2 or mb1-CreER T2 ;Syk fl/fl mice in the absence or presence of BAFF <ref type="bibr">(Fig 6A)</ref>.</s><s>Without BAFF, most B cells die within 3 days, whereas in the presence of BAFF, the B-cell cultures can be maintained for longer times.</s><s>After 8 days of culture, 60% of the control and only 30% of the Syk-negative B cells were still viable <ref type="bibr">(Fig 6A)</ref>.</s><s>This difference in the response to BAFF could not be due to an altered BAFF-R expression as the B cells from both mouse strains expressed similar amounts of BAFF-R on their surface (Fig <ref type="figure" target="#fig_9">6B</ref>).</s></p><p><s>We next studied the BAFF dependence of Syk-negative B cells in vivo by injecting Tam-treated mb1-CreER T2 ;Syk fl/fl mice with either 5A12 or 9B9 anti-BAFF-R antibodies, only the latter of which blocks BAFF binding to the receptor, and thus BAFF-R-mediated survival signals <ref type="bibr">(Fig 6C)</ref>.</s><s>A recent study revealed that treatment of WT mice with the 9B9 antibody resulted in the elimination of 80% of the mature B cells <ref type="bibr" target="#b48">(Rauch et al, 2009)</ref>.</s><s>Similarly, injection of Taminduced mb1-CreER T2 ;Syk fl/fl mice with the 9B9 antibody resulted in a tenfold reduction in the absolute number of splenic B cells.</s><s>The non-blocking 5A12 antibody injection has no effect on the B-cell numbers.</s><s>The reduction in Syk-negative B cells in anti-9B9-treated mice was observed to a different extent in different lymphatic tissues, including the SP, <ref type="bibr">LN and PC (Fig 6D)</ref>.</s><s>A study of the mature follicular B-cell frequencies in the blood from control and B-cellspecific Syk-deficient mice revealed no significant difference in the kinetics of B-cell elimination at several time points (day 3 to day 15) after anti-BAFF-R treatment <ref type="bibr">(Supplementary Fig S9)</ref>.</s></p><p><s>These data indicate that Syk-negative B cells are, to a certain extent, responsive to BAFF and depend on BAFF-BAFF-R interactions for their long-term in vivo survival.</s><s>The Syk family kinase ZAP-70 can partially replace Syk function in Syk-deficient pre-B cells <ref type="bibr" target="#b54">(Schweighoffer et al, 2003)</ref>.</s><s>Therefore, one possibility for the longterm survival of Syk-negative mature B cells could be the expression of ZAP-70.</s><s>To test this, B cells from mb1-CreER T2 ;Syk fl/fl mice were subjected to immunoblot and flow cytometric analyses.</s><s>However, no ZAP-70 expression was detected in these cells <ref type="bibr">(Supplementary Fig S10)</ref>.</s><s>In line with these data, the Syk-negative mature B-cell population is not affected in mice lacking ZAP-70 (data not shown).</s><s>A Ex vivo survival assay performed on mature splenic B cells isolated from Tam-treated mb1-CreER T2 or mb1-CreER T2 ;Syk fl/fl mice.</s><s>The cells were cultured in the presence (dashed lines) or absence (solid lines) of 100 ng/ml human recombinant BAFF and harvested at the indicated time points.</s><s>Viable cells were identified by flow cytometry using CD19 versus 7-AAD staining.</s><s>Shown are means AE SD from a triplicate experiment representative of at least three independent experiments.</s><s>B Histogram representation of the BAFF-R surface staining on mature B cells from Tam-treated mb1-CreER T2 ;Syk fl/fl (solid line) or control mb1-CreER T2 mice (dashed line).</s><s>Splenic transitional B cells derived from the BAFF-R À/À mouse strain served as a negative control (dotted line).</s><s>C Quantitative analysis of absolute splenic B-cell numbers from Tam-treated mb1-CreER T2 (filled circles) or mb1-CreER T2 ;Syk (open circles), mb1-CreER T2 ;Syk fl/fl ;CD19 À/À (open squares) and mb1-CreER T2 ;Syk fl/fl ;CD19 À/À ;FoxO fl/fl (open diamonds).</s><s>An asterisk (*) marks statistically significant differences (P &lt; 0.05); two asterisks (**) indicate a P &lt; 0.01.</s><s>P-values were obtained by a two-tailed Student's t-test.</s><s>Shown are data from three to four mice per group.</s><s>E, F Intracellular flow cytometric analysis of (E) Syk and (F) FoxO1 in mb1-CreER T2 ;Syk fl/fl ;CD19 À/À (dashed line) and mb1-CreER T2 ;Syk fl/fl ;CD19 À/À ;FoxO fl/fl (solid line) B cells.</s><s>In (E), B cells from mb1-CreER T2 mice served as a positive control for the Syk staining (dotted line).</s><s>In (F), T cells from mb1-CreER T2 ;Syk fl/fl ;CD19 À/À ;FoxO fl/fl mice served as a positive control for FoxO1 expression showing that FoxO1 deletion was B cell specific.</s><s>Thus, the PI3K signaling pathway is indeed likely to be induced by CD19, to support the survival of Syk-negative B cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The survival of Syk-and CD19-negative B cells is rescued by</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Absolute number of cells Absolute number of cells</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Absolute number of cells Absolute number of cells</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>We show here that approximately 25% of the mature peripheral B cells can survive in the mouse for at least 2 months without Syk, in a manner that requires BAFF-R and CD19 signaling.</s><s>In contrast, deletion of the Syk gene in early B cells results in the appearance of a small number of immature IgM + B cells, which, however, fail to give rise to any mature B cells in the periphery <ref type="bibr" target="#b9">(Cheng et al, 1995)</ref>.</s><s>Thus, pre-B and mature B cells have different requirements for Syk.</s><s>Indeed, the pre-BCR is an autonomously signaling receptor that continuously engages Syk, whereas the BCR forms an autoinhibited oligomer on mature B cells that is not in contact with Syk.</s><s>This notion is supported by a proximity ligation analysis showing that Syk is localized near the BCR only after BCR activation <ref type="bibr" target="#b27">(Infantino et al, 2010;</ref><ref type="bibr" target="#b30">Klasener et al, 2014)</ref>.</s><s>The presence of large amounts of Syk-negative mature B cells in the induced mb1-CreER T2 ;Syk fl/fl mice allowed us to analyze the in vivo role of this kinase in the activation of mature B cells.</s><s>Our finding, that in the absence of Syk, mature B cells have a defective Ca 2+ response, is consistent with an earlier study in Syk-negative DT40 B cells <ref type="bibr" target="#b58">(Takata et al, 1994)</ref>.</s><s>This signaling defect is explained by the finding that the phosphorylation of the adaptor protein SLP-65/BLNK by Syk is required for the organization of a functional Ca 2+ signalosome.</s><s>Signals from membrane proteins that are functionally connected to the BCR, such as CD38 and RP105, are also defective in Syk-negative B cells <ref type="bibr" target="#b37">(Lund et al, 1996;</ref><ref type="bibr" target="#b8">Chan et al, 1998;</ref><ref type="bibr" target="#b65">Yazawa et al, 2003)</ref>.</s><s>Other receptor systems, however, such as CD40 and the innate immunity receptors TLR9 are not affected by the loss of Syk.</s></p><p><s>While the number of mature B cells is reduced only threefold in the induced mb1-CreER T2 ;Syk fl/fl mice, other B-cell subpopulation such as MZ B cells are reduced more than tenfold in the absence of Syk.</s><s>This is surprising as MZ B cells are regarded as a more innate B-cell population that requires exposure to innate receptor stimuli for their maintenance and expansion <ref type="bibr" target="#b7">(Cerutti et al, 2013)</ref>.</s><s>However, it is feasible that Syk is not only involved in signaling from the activated BCR, but also in B-cell migration and/or adhesion.</s><s>In neutrophils and macrophages, Syk is involved in signaling from integrin and chemokine receptors <ref type="bibr" target="#b40">(Mocsai et al, 2010)</ref>.</s><s>Indeed, we found that Syk-negative B cells display a defective CXCL12-driven chemotactic behavior <ref type="bibr">(Supplementary Fig S5)</ref>.</s><s>Recently, it was shown that Syk phosphorylates the F-actin-binding protein SWAP-70, resulting in altered chemotaxis and polarization of B cells, particularly to CXCL12 <ref type="bibr" target="#b45">(Pearce et al, 2011)</ref>.</s><s>Interestingly, SWAP-70 À/À mice also show reduced numbers of MZ B cells <ref type="bibr" target="#b10">(Chopin et al, 2010)</ref>.</s><s>A loss of Syk might lead to a failure of T2 B cells to migrate to the MZ and thus to lower amounts of MZ B cells <ref type="bibr" target="#b39">(Miosge &amp; Goodnow, 2005)</ref>.</s></p><p><s>It is not clear at present why 70% of the mature B cells disappear in the induced mb1-CreER T2 ;Syk fl/fl mice.</s><s>Our transfer experiments, and the deletion of Syk in combination with an anti-IL-7R treatment, show that this loss is not primarily due to reduced production of mature B cells but is a feature of mature B cells themselves.</s><s>Syk is also needed for the migration of transitional T0 B cells into the white pulp region of the spleen, where the cells develop into T1 B cells and receive additional survival signals <ref type="bibr" target="#b22">(Henderson et al, 2010)</ref>.</s><s>Thus, a migration and/or adhesion defect, as discussed above, could be the cause of the loss of the mature B2 B cells in the induced mb1-CreER T2 ;Syk fl/fl mice.</s><s>For example, if locally defined survival niches exist in the periphery that mature B cells need to visit from time to time to ensure their long-term survival, a defective migration of Syk-negative B cells would result in reduced cell numbers.</s><s>Alternatively, within the cell, Syk may send a tonic signal to the mTOR pathway that controls the "fitness" of mature B cells.</s><s>At least in B-cell tumor cells, such a Syk-mTOR connection has been described <ref type="bibr" target="#b34">(Leseux et al, 2006;</ref><ref type="bibr" target="#b16">Fruchon et al, 2012;</ref><ref type="bibr" target="#b6">Carnevale et al, 2013)</ref>.</s><s>In line with this, we found that Syk-deficient mature B cells do not activate mTORC1 when stimulated with anti-Kappa F(ab 0 ) 2 (Supplementary Fig S4 <ref type="figure">)</ref>.</s></p><p><s>Based on the finding that Syk-negative B cells respond less well to BAFF in culture, Schweighoffer et al suggested that Syk is an essential common component of the BCR and the BAFF-R, both of which mediate B-cell survival signaling <ref type="bibr" target="#b55">(Schweighoffer et al, 2013)</ref>.</s><s>Our study confirms that in culture, Syk-negative B cells respond less well to the pro-survival factor BAFF.</s><s>However, we also found that Syknegative B cells still respond to BAFF in vivo and require this factor for their long-term survival in the mouse.</s><s>Thus, an unresponsiveness to BAFF is not the reason for the reduction of the Syk-negative B cells in induced mb1-CreER T2 ;Syk fl/fl mice.</s><s>Another discrepancy between these two studies is that we, in contrast to Schweighoffer et al, find a significant reduction in the B1 B-cell population in the induced mb1-CreER T2 ;Syk fl/fl mice.</s><s>B1 B cells are polyreactive, slowly renewing cells that are strongly affected by the loss of positive BCR signaling components <ref type="bibr" target="#b3">(Berland &amp; Wortis, 2002)</ref>.</s><s>The reduction in the B1 B-cell numbers in the absence of Syk is in line with these studies.</s><s>We have found that under certain conditions, B1 B cells can escape Cremediated deletion of the floxed Syk gene <ref type="bibr" target="#b1">(Alsadeq et al, 2014</ref>).</s><s>An incomplete Syk gene deletion may be the reason for this discrepancy.</s><s>We verified by intracellular staining that Syk was indeed deleted in the B1 B-cell population that was still present in the induced mb1-CreER T2 ;Syk fl/fl mice.</s></p><p><s>The PI3K pathway can promote the survival of WT and Syk-deficient B cells.</s><s>The importance of this pathway for B-cell survival was recently demonstrated in mice with a B-cell-specific activation of PI3K signaling via a dominant-active form of the p110a subunit <ref type="bibr" target="#b57">(Srinivasan et al, 2009)</ref>.</s><s>In these mice, B cells survive, even in the absence of BCR expression.</s><s>Schweighoffer et al have shown that the survival of Syk-deficient B cells can be rescued, at least in part by the activation of the PI3K pathway (by deleting PTEN).</s><s>The BCR coreceptor CD19 is a well-known PI3K activator, and we find that its expression is required for the survival of Syk-deficient B cells.</s><s>The cytoplasmic tail of CD19 is phosphorylated by the Src-family kinase Lyn, thus allowing CD19 to connect to the p85/p110 PI3K module.</s><s>It is thus not a surprise that CD19 can still be phosphorylated and function in the absence of Syk, although it was shown that Syk can also function upstream of PI3K in BCR signaling <ref type="bibr" target="#b2">(Beitz et al, 1999)</ref>.</s><s>We recently found that CD19 is in close association with the IgD-BCR on resting B cells <ref type="bibr" target="#b30">(Klasener et al, 2014)</ref>.</s><s>However,</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Syk knockout mice</head><p><s>To delete Syk in mature B cells, the Syk fl/fl mouse strain, kindly provided by Prof. A. Tarakhovsky, was mated with mice expressing CreER T2 in a B-cell-specific manner (mb1-CreER T2 ).</s><s>The CreER T2 insert was kindly provided by Prof. P. Chambon <ref type="bibr" target="#b15">(Feil et al, 1997)</ref>.</s></p><p><s>The resulting mb1-CreER T2 ;Syk fl/fl mice express a Tam-inducible form of the Cre recombinase under the control of the mb-1 promoter, the mb-1 gene (encoding the Ig-a protein) being B-cellspecific and expressed throughout B-cell development.</s><s>In these mice, Tam treatment induces Cre activity and deletion of Syk in all B-cell subsets that have matured beyond the early pro-B-cell stage.</s><s>The CD19 À/À strain has been described previously <ref type="bibr" target="#b64">(Yasuda et al, 2013)</ref> and was kindly provided by Dr. M. Schmidt-Supprian.</s><s>The FoxO1 f/f mouse strain was described in <ref type="bibr" target="#b44">Paik et al (2007)</ref>.</s><s>All animal studies were absolved randomly and blindly on mice aged between 8 and 12 months and were carried out in accordance with the German Animal Welfare Act, having been reviewed by the regional council and approved under the license # G-09/103.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Tam treatment</head><p><s>Mice were treated by oral gavage with 6 mg of tamoxifen (Tam) citrate (Ratiopharm) dissolved in 20% ClinOleic acid (Baxter).</s><s>The animals were treated for a total of five times at 3-day intervals and were then sacrificed 5 days after the last treatment, at day 20.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isolation of genomic DNA and PCR analysis</head><p><s>Genomic (g) DNA was obtained from purified mature splenic and LN-derived B cells or from BM B cells culture using the Quick-gDNA MicroPrep isolation kit (Zymo Research).</s><s>Amplification of the gDNA was achieved by PCR using following oligonucleotides primers.</s><s>Syk F (d-band): 5 0 -GCC CGT TCT GTG CCT ACT GG-3 0 and 5 0 -GCT GGT TCC CTT TTC CTT CC-3 0 ; Syk F2 (f/+-band): 5 0 -GCC CGT TCT GTG CCT ACT GG-3 0 and 5 0 -TAC CTA ACC AAA CCC ACG GC-3 0 , TC21 (loading control): 5 0 -GGA TCA TGT TGT GGA GTT CGT GC-3 0 ; 5 0 -GTC CAA GAA GAC ATG GAT GGG GG-3 0 .</s><s>mRNA isolation and RT-PCR Total mRNA was isolated from whole mature B cells using the TRI Reagent kit (Sigma).</s><s>B cells (5 × 10 6 ) were lysed in TRI Reagent, and mRNA was isolated by chloroform/isopropanol precipitation.</s><s>After ethanol washing and centrifugation, the RNA pellets were airdried and resuspended in DEPC-treated water.</s><s>RNA content was measured, and aliquots of 0.1 lg mRNA were reverse-transcribed using the first-strand cDNA synthesis kit (Fermentas) according to the manufacturer's instructions.</s><s>Amplification of the Syk cDNA was achieved by PCR using the primers Syk-cDNA-for: 5 0 -TGA GGA CCT GAA GGA GAA CC-3 0 and Syk-cDNA-rev: 5 0 -AGG CTT TGG GAA GGA GTA GG-3 0 and running 30 cycles with an annealing step at 60°C.</s><s>For the amplification of the Hprt-cDNA, the DNA primers HPRT-F: 5 0 -GCT GGT GAA AAG GAC CTC T-3 0 and HPRT-R: 5 0 -CAC AGG ACT AGA ACA CCT GC-3 0 were used.</s><s>PCR products were then separated and analyzed by agarose gel electrophoresis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunoblot analysis</head><p><s>For immunoblotting, the samples were separated by denaturing SDSgel electrophoresis, transferred onto a nitrocellulose membrane and probed with anti-Syk (N19; rabbit anti-mouse; Santa Cruz) or anti-ZAP-70 (N15; goat anti-mouse; Santa Cruz).</s><s>Detection of GAPDH (Calbiochem) was used to demonstrate the amount of total protein loaded.</s><s>Prior to incubation with the primary antibody (Ab), the membrane was blocked with PBS containing 5% milk powder and subsequently washed.</s><s>Incubation of the membrane with the primary Ab diluted in PBS supplemented with 0.5% BSA (PAA Laboratories) and 0.1% NaN 3 (Sigma) was performed for 1 h at room temperature (RT), followed by washing steps with PBS.</s><s>Incubation with the secondary Ab, diluted in PBS, was carried out for 1 h at RT. Excess Ab was washed off, and immuno-reactive proteins were detected by the ECL chemoluminescence detection system (Amersham).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Intracellular cell staining</head><p><s>Intracellular cell staining was performed using the ADG fix&amp;perm kit (Dianova) according to the manufacturer's instructions.</s><s>After fixation and permeabilization, cell suspensions isolated from various lymphoid organs were washed in saponin-based buffer (PBS; 0.5% saponin (Sigma); 0.2% BSA; 0.02% NaN 3 ) and subsequently in FACS buffer (PBS; 3% FCS (PAN Biotech); 0.05% NaN 3 ).</s><s>Intracellular staining was performed using anti-Syk Ab (BioLegend, clone 5F5 or clone SYK-01) labeled with Zenon Alexa 647 (Invitrogen).</s><s>Detection of ZAP-70 was performed using anti-ZAP-70-PE (eBioscience, clone 1E7.2).</s><s>The detection of pY was carried out by staining with directly labeled anti-pY Ab (BioLegend, clone PY20 labeled with Alexa Fluor 647).</s><s>The detection of FoxO1 was performed using anti-FoxO1 Ab (Cell Signaling, clone C29H4, rabbit anti-mouse IgG) and anti-rabbit IgG DyLight 649 (BioLegend, clone Poly4064).</s><s>The detection of S6 phosphorylation was performed using a directly labeled anti-pS6 Ser240/244 Ab (Cell Signaling, clone D68F8, labeled with PE).</s><s>The fixable viability dye eFluor450 (eBioscience) was used in some cell culture experiments.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MACS depletion and cell sorting</head><p><s>Splenic B cells were obtained by MACS-based negative selection using the magnetically labeled B-cell isolation kit (Miltenyi Biotec) according to the manufacturer's instructions.</s><s>The cells were separated by AutoMACS (Miltenyi Biotec).</s></p><p><s>The Abs used in the flow cytometry studies were anti-IgM-PE, anti-IgM-Cy5, anti-IgM-DyLight649, anti-IgD-PE, anti-CD93-APC, anti-CD21-FITC, anti-CD23-PE, anti-CD5-PerCP-Cy5.5, anti-B220-PE, anti-biotin-PE (Becton and Dickinson, eBioscience, or Jackson) and biotinylated anti-BAFF-R (R&amp;D).</s></p><p><s>CD93 À (mature) and CD93 + (transitional) B cells were obtained by cell sorting using FACSAria (Becton Dickinson) or Dako Cytomation MoFlo (Dako) cell sorters.</s><s>After FACSort separation, the B cells were analyzed for purity and viability using an anti-CD19 Ab (Bio-Legend clone 6D5) and 7-AAD (eBioscience), respectively.</s></p><p><s>Ca 2+ influx measurement Ca 2+ influx in mature CD93 À B cells was measured using the intracellular fluorescent dye Indo-1 (Invitrogen) and the LSRII flow cytometer (Becton Dickinson).</s><s>Cells (0.5-1 × 10 6 ) were resuspended in 1 ml plain Iscove's medium (Biochrom AG) supplemented with 1% FCS.</s><s>The Indo-1 dye was prepared 5 min prior to incubation with the cell samples and consisted of 25 ll Indo-1 (dissolved in DMSO), 25 ll Pluronic F-127 (Invitrogen) and 113 ll FCS.</s><s>Indo-1 aliquots (15 ll) were then added to each sample, and cell samples were incubated for 45 min at 37°C protected from light.</s><s>Cells were then centrifuged at 300 × g and 4°C.</s><s>For analysis, the cell pellets were resuspended in 500 ll of Iscove's medium supplemented with 1% FCS.</s><s>The stimuli used in the experiments included 10 lg/ml polyclonal anti-IgM F(ab 0 ) 2 (Jackson Lab), 10 lg/ml anti-IgD (eBioscience, clone 10.4.22), 1 lM Ionomycin (Enzo) and 1 lM latrunculin A (Cayman).</s></p><p><s>Transfer of mature B cells into Rag2 À/À ;c c À/À Mature splenic B cells (CD19 + CD93 À ) (1 × 10 7 ) from mb1-CreER T2 or mb1-CreER T2 ;Syk fl/fl mice were isolated by negative selection using the B-cell isolation kit (Miltenyi) in combination with anti-CD93 Ab and transferred into Rag2 À/À ;c c À/À mice intravenously (i.v.).</s><s>Recipient mice were treated with Tam every third day, and cell populations were analyzed by flow cytometry 20 days after the transfer.</s><s>For WT versus Syk fl/fl competition experiments, mature splenic B cells (CD19 + CD93 + ) from WT mice (1 × 10 7 ) carrying a GFP reporter construct <ref type="bibr" target="#b47">(Pelanda et al, 2002b)</ref> or mature splenic B cells mb1-CreER T2 ;Syk fl/fl mice (1 × 10 7 ) were purified as described above and injected i.v.</s><s>into Rag2 À/À ;c c À/À mice at a ratio of 1:1.</s></p><p><s>The recipient mice were treated with Tam every third day until day 30 post-transfer.</s><s>SP was then analyzed by flow cytometry.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Treatment of mice with anti-BAFF-R Ab</head><p><s>The mb1-CreER T2 and mb1-CreER T2 ;Syk fl/fl mice were treated with Tam 5 times.</s><s>At day 15 after Tam treatment, the deletion of Syk was confirmed by intracellular flow cytometric analysis as well as in an activation assay, in which Syk-deficient B cells were non-responsive to BCR stimulation (as shown in Fig <ref type="figure">4A</ref>).</s><s>The mice were then injected i.v. with 0.5 mg of anti-BAFF-R-blocking Ab (rat antimouse, clone 9B9) or the isotype control, which binds to BAFF-R but does not interfere with the BAFF-BAFF-R interaction (nonblocking, rat anti-mouse, clone 5A12) <ref type="bibr" target="#b48">(Rauch et al, 2009)</ref>.</s><s>Mice were treated with Tam every third day and were analyzed at days 3, 5, 7, 9 and 15 after anti-BAFF-R treatment when lymphocyte subpopulations in the blood, SP, LN, PP, and PC were analyzed by flow cytometry.</s></p><p><s>Treatment of mice with anti-IL-7R Ab mb1-CreER T2 ;Syk fl/fl were treated with Tam for 35 days every third day.</s><s>After confirming the deletion of Syk by intracellular staining day 20 after Tam treatment, mice were injected i.v. with 1 mg of anti-IL-7R-blocking Ab (rat anti-mouse, clone A7R34, BXCell and homemade).</s><s>Mice remained under anti-IL-7R treatment every third day until day 40 after anti-IL-7R-treatment when lymphocyte subpopulations in the SP, BM, LN, PP and PC were analyzed by FACS.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ex vivo activation and proliferation experiments</head><p><s>Splenic B lymphocytes were purified by negative selection after incubation with magnetic beads (see MACS depletion and cell sorting).</s><s>CD19 + CD93 À mature B cells (1 × 10 5 ) were cultured in 0.2 ml complete Iscove's cell culture medium (Biochrom AG) supplemented with 10% FCS.</s><s>The cells were either left unstimulated or were incubated in the presence of the following stimuli: 10 lg/ml polyclonal anti-IgM F(ab 0 ) 2 (Jackson immunoresearch, goat anti-mouse polyclonal, catalog #115-006-075), 10 lg/ml anti-RP105 (eBioscience, clone RP/14), 10 lg/ml anti-CD38 (eBioscience, clone 90), 10 lg/ml anti-CD40 (eBioscience, clone 1C10), and 10 ng/ml mIL-4 (Miltenye Biotec); 2.5 lg/ml unmethylated CpG oligonucleotides (Invivogen, ODN 1826); and 10 lg/ml LPS (Sigma).</s><s>The cells were harvested after 24 h of stimulation, and expression of the activation marker CD86 was analyzed by flow cytometry using anti-CD86 staining (eBioscience, clone GL1).</s><s>To discriminate viable and dead cells, 7-AAD was added to each sample.</s><s>Proliferation of mature B cells was measured using the eFluor 670 proliferation dye (eBioscience).</s><s>Mature CD93 À B cells (2 × 10 6 ) were labeled with eFluor 670 prior to cultivation according to manufacturer's instruction.</s><s>Aliquots of 1 × 10 5 mature B cells were then cultured in 0.2 ml complete Iscove's medium with 10% FCS for 72 h and were either left unstimulated or stimulated with anti-RP105, anti-IgM alone, anti-IgM and anti-CD40, anti-CD40 alone or unmethylated CpG oligonucleotides at the concentrations described above.</s><s>Proliferation was measured by flow cytometry.</s><s>Once again, 7-AAD staining was included in the analysis to discriminate between viable and dead cells.</s><s>Phosphorylation of total intracellular pY was measured after stimulation of purified B cells with 50 lM pervanadate/H 2 O 2 (Sigma/Merck) for 5 min at 37°C.</s><s>The pervanadate/H 2 O 2 solution was prepared as described <ref type="bibr" target="#b60">(Wienands et al, 1996)</ref>.</s><s>Cells were fixed immediately after phosphorylation and subjected to intracellular staining.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ex vivo survival assays</head><p><s>Purified splenic B cells were cultured in complete Iscove's medium supplemented with 10% FCS in the absence or presence of 100 ng/ml human recombinant (hr) BAFF (R&amp;D) over a period of 8 days.</s><s>The medium, supplemented with fresh hrBAFF, was exchanged every second day.</s><s>The cells were harvested and analyzed by flow cytometry.</s><s>Dead cells were excluded using 7-AAD and Annexin V staining.</s><s>The EMBO Journal Survival of mature murine B cells without Syk Elias Hobeika et al Generation of mb1-CreER T2 ;Syk fl/fl ;CD19 À/À and mb1-CreER T2 ; Syk fl/fl ,CD19 À/À ; FoxO1 fl/fl mice To generate the mb1-CreER T2 ;Syk fl/fl ;CD19 À/À mouse strain, mb1-CreER T2 ;Syk fl/fl mice were crossed to CD19-CreER T2 mice expressing CreER T2 from the CD19 locus and therefore lacking CD19 expression in the homozygous state (Mark Schmidt-Supprian, personal communication and <ref type="bibr" target="#b64">Yasuda et al, 2013)</ref>.</s><s>To generate the mb1-CreER T2 ; Syk fl/fl ;CD19 À/À ;FoxO1 fl/fl mouse strain, mb1-CreER T2 ;Syk fl/fl ; CD19 À/À mice were crossed to FoxO1 fl/fl mice <ref type="bibr" target="#b44">(Paik et al, 2007)</ref>.</s><s>The mb1-CreER T2 Syk fl/fl inducible mice (control for the CD19;Syk double-deficient mice) have one copy of CD19-CreER T2 .</s><s>The CD19 À/À controls harbor mb1-CreER T2 .</s><s>The animals were treated with Tam for a total of 10 times at 3-day intervals, and the cells were subsequently analyzed 5 days after the last induction by flow cytometry.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ex vivo stimulation for pS6 detection</head><p><s>The phosphorylation of S6 was measured after stimulation of purified mature B cells (1 × 10 5 cells) from mb1-CreER T2 and mb1-CreER T2 ;Syk fl/fl mice at day 20 after Tam treatment.</s><s>Purified mature Syk-deficient B cells and the control cells were cultured overnight (O/N) in complete Iscove's medium with 3% FCS.</s><s>The cells were then stimulated with 10 lg/ml anti-Kappa F(ab 0 ) 2 , for 10 min (goat anti-mouse Polyclonal von Southern Biotech catalog# 1052-14).</s><s>To assess the specificity of the anti-pS6 Ab, the cells were pre-treated with 500 nM rapamycin for 1 h and were stimulated with anti-Kappa F(ab 0 ) 2 for additional 10 min.</s><s>Stimulation with 50 lM pervanadate/H 2 O 2 (Sigma/Merck) for 5 min at 37°C served as a positive control for the phosphorylation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vitro migration assay</head><p><s>Cell migration was measured using 8-lm Transwell inserts (Greiner) for 24-well plates (Greiner).</s><s>Iscove's medium/3% FCS alone or supplemented with either 1 lg/ml CCL21, 0.2 lg/ml CXCL12 or 1 lg/ml CXCL13 (PeproTech) was added to the wells, and purified mature B cells (2 × 10 5 cells) from mb1-CreER T2 and mb1-CreER T2 ; Syk fl/fl mice at day 10 after Tam treatment were added into the inserts.</s><s>The cells were allowed to migrate for 2.5 h at 37°.</s><s>The number of migrated cells and the number of cells in the insert were measured by flow cytometry for 1 min.</s><s>Dead cells were excluded using 7-AAD.</s><s>The relative migration was calculated, and specific migration was determined by subtracting the relative unspecific migration without stimulus from the relative migration in response to the chemokines.</s><s>The surface expression of CXCR4 (receptor for CXCL12) and CXCR5 (receptor for CXCL13) was assessed by flow cytometry using anti-CXCR4-BrilliantViolet421 (BioLegend) and anti-CXCR5-PE (BD) Abs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Unpaired two-tailed Student's t-tests (with n between three and five mice per group) were carried out using Prism 4 software (GraphPad Software Inc) to determine the statistical relevance of differences between groups.</s><s>In all the carried experiments, the results are representative of at least three independent experiments.</s></p><p><s>Supplementary information for this article is available online:</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>EMBO Journal Vol 34 | No 7 | 2015 ª 2015 The Authors The EMBO Journal Survival of mature murine B cells without Syk Elias Hobeika et al Syk fl/fl mice showing the appearance of Syk-positive B cells at day 5 but not day 2 after induction (Supplementary Fig S2).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Deletion of Syk after Tam treatment of mb1-CreER T2 ;Syk fl/fl mice.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>Upper row: amplification of floxed (fl) and wt (+) alleles.</s><s>Middle row: amplification of the deleted (d) allele.</s><s>Lower row: loading control (TC21, a gene unaffected by the deletion of Syk).</s><s>Established control DNA was used to visualize the individual bands (as indicated).</s><s>ª 2015 The Authors The EMBO Journal Vol 34 | No 7 | 2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Relative and absolute cell numbers of B-cell populations in induced mb1-CreER T2 ;Syk fl/fl mice.</s><s>A, B Flow cytometric analysis of B cells from (A) the BM and (B) the SP of mb1-CreER T2 control (left) and mb1-CreER T2 ;Syk fl/fl mice (right) treated with Tam as described in the Materials and Methods section.</s><s>The BM cells were stained with anti-IgM and anti-B220, and the SP cells with anti-CD19 and anti-CD93 or anti-CD23 and anti-CD21.</s><s>The gated regions in the dot blots correspond to individual B-cell populations: (A) Bone marrow: gate P (B220 + IgM À ) pro-/pre-B cells, gate I (B220 lo IgM + ) immature B cells, gate M (B220 hi IgM + ) mature B cells; (B) spleen: gate T (CD19 + CD93 + ) transitional (T) B cells, gate M (CD19 + CD93 À ) mature B cells; in CD93 À splenic B cells, gate M (CD23 hi CD21 int CD93 À ) mature follicular B cells and gate MZ (CD23 lo CD21 hi CD93 À ) marginal zone B cells.</s><s>The numbers in the dot plots indicate the mean relative frequency of cells in the gate.</s><s>C-E Statistical analysis of absolute cell numbers per Tam-treated mouse: filled circles indicating cells obtained from mb1-CreER T2 control mice and open circles from mb1-CreER T2 ;Syk fl/fl mice.</s><s>(C) Statistical analysis of the absolute cell numbers of pro-/pre-, immature and mature recirculating B cells in the BM.</s><s>(D) Absolute cell numbers of transitional, M and MZ B cells found in the SP.</s><s>(E) Statistical analysis of the absolute cells numbers of peritoneal B cell subsets B1-a and B1-b.</s><s>An asterisk (*) marks statistically significant differences (P &lt; 0.05), two asterisks (**) indicate P &lt; 0.01, P-values were obtained using two-tailed Student's t-test.</s><s>Cell numbers of four to five mice per group are shown, with each dot representing an individual animal.</s><s>Data information: The results are representative of three independent experiments.</s></p></div></figDesc><graphic coords="4,209.56,385.28,89.32,89.32" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3.</s><s>Effect of syk deletion on B-cell stimulation.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc><div><p><s>Data information: Data shown are representative of three independent experiments.</s><s>ª 2015 The Authors The EMBO Journal Vol 34 | No 7 | 2015 Elias Hobeika et al Survival of mature murine B cells without Syk The EMBO Journal lesser extent with LPS.</s><s>This shows that the latter receptors do not require Syk for signaling in mature B cells.</s><s>The results of a B-cell proliferation assay mirrored those of the CD86 expression analyses.</s><s>Syk-negative B cells underwent fewer cell division cycles when cultured in the presence of anti-IgM F (ab 0 ) 2 or anti-RP105 antibodies (Fig 4B).</s><s>Simultaneous signaling via BCR and CD40 exacerbated the differences in proliferation between Syk-negative and Syk-expressing B cells, whereas treatment of B cells with TLR9-activating CpG led to a similar rate of proliferation in both types of B cells (Fig 4B).</s><s>The absence of Syk in the proliferating mb1-CreER T2 ;Syk fl/fl -derived B-cell population was verified by flow cytometric analysis of intracellular Syk expression (Supplementary Fig S6).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head></head><label></label><figDesc><div><p><s>numbers of mature B cells derived from the spleen of either mb1-CreER T2 ;Syk fl/fl mice or mice expressing EGFP specifically in B cells (Fig5C).</s><s>B cells in the injected mice were harvested 5 days after the</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 4 .Figure 5 .</head><label>45</label><figDesc><div><p><s>Figure 4. Mature B cells deficient in Syk are not activated and do not proliferate when stimulated via the BCR.A Ex vivo activation assay of splenic mature B cells from Tam-treated mb1-CreER T2 (upper row) or Tam-treated mb1-CreER T2 ;Syk fl/fl mice (lower row).</s><s>Purified splenic B cells were either left unstimulated (medium) or were stimulated with the indicated stimuli.</s><s>The cells were analyzed by flow cytometry after 24 h.</s><s>Shown are CD19 versus CD86 dot plots.</s><s>7-AAD was included to distinguish dead from viable cells.</s><s>The numbers in the quadrants indicate the relative frequencies of cells in the gate.</s><s>B Ex vivo proliferation assay with mature B cells from Tam-treated mb1-CreER T2 (upper row) or Tam-treated mb1-CreER T2 ;Syk fl/fl mice (lower row).</s><s>The cells were incubated with the indicated stimuli for 90 h.Data information: Data shown are representative of three independent experiments.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head></head><label></label><figDesc><div><p><s>FoxO1 deletionRecent experiments implicate the PI3K signaling pathway in the survival and maintenance of mature B cells in the periphery</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Figure 6 .</head><label>6</label><figDesc><div><p><s>Figure 6.</s><s>Mature B cells lacking Syk remain dependent on BAFF-R for their survival in vivo and in vitro.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head>Figure 7 .</head><label>7</label><figDesc><div><p><s>Figure 7. Induction of Syk deletion in the absence of CD19 and FoxO1.A, B B lymphocytes derived from mb1-CreER T2 ;Syk fl/fl (first panel), CD19 À/À (second panel), mb1-CreER T2 ;Syk fl/fl ;CD19 À/À (third panel) and mb1-CreER T2 ;Syk fl/fl ;CD19 À/À ; FoxO fl/fl (fourth panel) mice were analyzed by flow cytometry after Tam treatment (see Materials and Methods).(A)</s><s>Flow cytometric analysis of BM-derived (A) or splenic (B) B cells.</s><s>IgM versus IgD dot plots representing B220 + CD43 À BM-derived B cells are depicted in (A).</s><s>The Fr. D, E, and F are distributed as indicated.</s><s>A CD19 versus B220 dot plot is depicted in (B).</s><s>C, D Statistical analysis of absolute B-cell numbers derived from the (C) the BM, Fr F and (D) splenic M B cells of mb1-CreER T2 ;Syk fl/fl (filled circles), mb1-CreER T2 ;CD19 À/À(open circles), mb1-CreER T2 ;Syk fl/fl ;CD19 À/À (open squares) and mb1-CreER T2 ;Syk fl/fl ;CD19 À/À ;FoxO fl/fl (open diamonds).</s><s>An asterisk (*) marks statistically significant differences (P &lt; 0.05); two asterisks (**) indicate a P &lt; 0.01.</s><s>P-values were obtained by a two-tailed Student's t-test.</s><s>Shown are data from three to four mice per group.</s><s>E, F Intracellular flow cytometric analysis of (E) Syk and (F) FoxO1 in mb1-CreER T2 ;Syk fl/fl ;CD19 À/À (dashed line) and mb1-CreER T2 ;Syk fl/fl ;CD19 À/À ;FoxO fl/fl (solid line) B cells.</s><s>In (E), B cells from mb1-CreER T2 mice served as a positive control for the Syk staining (dotted line).</s><s>In (F), T cells from mb1-CreER T2 ;Syk fl/fl ;CD19 À/À ;FoxO fl/fl mice served as a positive control for FoxO1 expression showing that FoxO1 deletion was B cell specific.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head>ª</head><label></label><figDesc><div><p><s>2015 The Authors The EMBO Journal Vol 34 | No 7 | 2015 Elias Hobeika et al Survival of mature murine B cells without Syk The EMBO Journal flow cytometric analysis (Fig 7E and F), indicating efficient Cremediated deletion of the floxed Syk and FoxO1 genes in these mice.</s><s>Interestingly, the ablation of FoxO1 expression restored the numbers of mature B cells to the levels of Syk or CD19 single-deficient B cells in both the BM and the SP (Fig 7A and B right panel; Fig 7C and D).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><head></head><label></label><figDesc><div><p><s>The EMBO Journal Vol 34 | No 7 | 2015 ª 2015 The Authors</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc><div><p><s>The EMBO Journal Vol 34 | No 7 | 2015 ª 2015 The Authors</s></p></div></figDesc><table><row><cell>The EMBO Journal</cell><cell>Survival of mature murine B cells without Syk</cell><cell>Elias Hobeika et al</cell></row><row><cell>whether CD19 inducibly or constitutively signals in Syk-deficient B</cell><cell></cell><cell></cell></row><row><cell>cells remains to be determined. One important downstream target of</cell><cell></cell><cell></cell></row><row><cell>the PI3K pathway is the transcription factor FoxO1, whose phos-</cell><cell></cell><cell></cell></row><row><cell>phorylation by Akt1 targets it for destruction. PI3K signaling can</cell><cell></cell><cell></cell></row><row><cell>thus be mimicked by a FoxO1 gene deletion, and we found that such</cell><cell></cell><cell></cell></row><row><cell>a deletion rescues mature Syk;CD19 double-deficient B cells from</cell><cell></cell><cell></cell></row><row><cell>elimination. This provides a direct proof that the survival of Syk-</cell><cell></cell><cell></cell></row><row><cell>deficient B cells involves not only BAFF but also PI3K signaling. In</cell><cell></cell><cell></cell></row><row><cell>conclusion, our study suggests that two different receptor systems,</cell><cell></cell><cell></cell></row><row><cell>namely BAFF-R and CD19, synergize to signal the survival not only</cell><cell></cell><cell></cell></row><row><cell>of Syk-deficient but also of wild-type B cells.</cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">http://emboj.embopress.org</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We are grateful to Prof. K. Rajewsky for the CD19 À/À , Prof. A. Tarakhovsky for the "floxed" Syk and Prof. R. De Pinho for the "floxed" FoxO1 mice.</s><s>We thank Prof. A. Rolink for the anti-BAFF-R Ab.</s><s>In addition, we thank Dr. P. Nielsen for reading the manuscript and for helpful scientific discussions.</s><s>This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294), by ERC-grant 32297, by the Deutsche Forschungsgemeinschaft through SFB746, TRR130, EXC294 and the CCI program "the German Federal Ministry of Education and Research" (BMBF 01 EO 0803).</s><s>The authors are responsible for the contents of this publication.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p><s>The authors declare that they have no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Aiba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kameyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Tedder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kurosaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="1497" to="1503" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The role of the syk/shp-1 kinase-phosphatase equilibrium in B cell development and signaling</title>
		<author>
			<persName><forename type="first">A</forename><surname>Alsadeq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hobeika</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Medgyesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Klasener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">193</biblScope>
			<biblScope unit="page" from="268" to="276" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">O</forename><surname>Beitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Fruman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kurosaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Cantley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Scharenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">274</biblScope>
			<biblScope unit="page" from="32662" to="32666" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Origins and functions of B-1 cells with notes on the role of CD5</title>
		<author>
			<persName><forename type="first">R</forename><surname>Berland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Wortis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="253" to="300" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor</title>
		<author>
			<persName><forename type="first">J</forename><surname>Brocard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Feil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chambon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Metzger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="4086" to="4090" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor</title>
		<author>
			<persName><forename type="first">A</forename><surname>Brunet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bonni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Zigmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Z</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Juo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Arden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Blenis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Greenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="857" to="868" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<author>
			<persName><forename type="first">J</forename><surname>Carnevale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Puissant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Banerji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Deangelo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stegmaier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">SYK regulates mTOR signaling in AML</title>
				<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="2118" to="2128" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cerutti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Puga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="118" to="132" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The molecular mechanism of B cell activation by toll-like receptor protein RP-105</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mecklenbrauker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Texido</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leitges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Carsetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Lowell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rajewsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miyake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarakhovsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page" from="93" to="101" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Syk tyrosine kinase required for mouse viability and B-cell development</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rowley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hayday</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Bolen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pawson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">378</biblScope>
			<biblScope unit="page" from="303" to="306" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">SWAP-70 controls formation of the splenic marginal zone through regulating T1B-cell differentiation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Chopin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Quemeneur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ripich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jessberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="3544" to="3556" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Cellular survival: a play in three Akts</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Datta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brunet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Greenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="2905" to="2927" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">CD19 function in central and peripheral B-cell development</title>
		<author>
			<persName><forename type="first">Del</forename><surname>Nagro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Otero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Anzelon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Omori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Kolla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Rickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Res</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="119" to="131" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Regulation of hemopoiesis by bone marrow stromal cells and their products</title>
		<author>
			<persName><forename type="first">K</forename><surname>Dorshkind</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="111" to="137" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Durand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hartvigsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fogelstrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Iritani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vanhaesebroeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Witztum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Puri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Gold</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="5673" to="5684" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains</title>
		<author>
			<persName><forename type="first">R</forename><surname>Feil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Metzger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chambon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">237</biblScope>
			<biblScope unit="page" from="752" to="757" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Fruchon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kheirallah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Al</forename><surname>Saati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ysebaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Laurent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Leseux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fournie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Laurent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bezombes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="795" to="805" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Poe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Jansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Lowell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Defranco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Tedder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="47" to="57" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Grabstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Waldschmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Finkelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Hess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Alpert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Boiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Namen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Morrissey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="257" to="264" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Competition for BLyS-mediated signaling through Bcmd/ BR3 regulates peripheral B lymphocyte numbers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Harless</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Lentz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Sah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Clise-Dwyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Hilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Cancro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Biol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1986" to="1989" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m" type="main">Progenitors for</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hayakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Hardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Herzenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Herzenberg</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Ly-1 B cells are distinct from progenitors for other B cells</title>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="1554" to="1568" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Henderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Grys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vehlow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>De Bettignies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zachacz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Henley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Batista</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Tybulewicz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">207</biblScope>
			<biblScope unit="page" from="837" to="853" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling</title>
		<author>
			<persName><forename type="first">S</forename><surname>Herzog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jumaa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="195" to="205" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">Testing gene function early in the B cell lineage in mb1-cre mice</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hobeika</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Thiemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jumaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pelanda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="13789" to="13794" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Indra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Warot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brocard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bornert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chambon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Metzger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="4324" to="4327" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Arginine methylation of the B cell antigen receptor promotes differentiation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Infantino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Benz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Waldmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">207</biblScope>
			<biblScope unit="page" from="711" to="719" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Context-specific BAFF-R signaling by the NF-kappaB and PI3K pathways</title>
		<author>
			<persName><forename type="first">J</forename><surname>Jellusova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Miletic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Cato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Shlomchik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Rickert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1022" to="1035" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Pleiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schneringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hippen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Cambier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="4596" to="4603" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main">B cell activation involves nanoscale receptor reorganizations and inside-out signaling by Syk</title>
		<author>
			<persName><forename type="first">K</forename><surname>Klasener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Maity</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hobeika</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e02069</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells</title>
		<author>
			<persName><forename type="first">F</forename><surname>Kohler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hug</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Eschbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Meixlsperger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hobeika</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wardemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jumaa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="912" to="921" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rajewsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1073" to="1083" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Expression and functional significance of an additional ligand for CTLA-4</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Lenschow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Zuckerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nabavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Jellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bluestone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="11054" to="11058" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Syk-dependent mTOR activation in follicular lymphoma cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Leseux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Hamdi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Al</forename><surname>Saati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Capilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Recher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Laurent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bezombes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="4156" to="4162" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Akt and mTOR in B cell activation and differentiation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Limon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Fruman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Immunol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">228</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Yin Yang 1 is a critical regulator of B-cell development</title>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schmidt-Supprian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hobeika</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Barteneva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jumaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pelanda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Skok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rajewsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1179" to="1189" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Lund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Howard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="1455" to="1467" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">B-cell stage and context-dependent requirements for survival signals from BAFF and the Bcell receptor</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mackay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Figgett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Saulep</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lepage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Hibbs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">237</biblScope>
			<biblScope unit="page" from="205" to="225" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Genes, pathways and checkpoints in lymphocyte development and homeostasis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Miosge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Goodnow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="318" to="335" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">The SYK tyrosine kinase: a crucial player in diverse biological functions</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mocsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ruland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Tybulewicz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="387" to="402" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">ITAM-mediated tonic signalling through pre-BCR and BCR complexes</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Monroe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="283" to="294" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The chemokine CXCL12 and regulation of HSC and B lymphocyte development in the bone marrow niche</title>
		<author>
			<persName><forename type="first">T</forename><surname>Nagasawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Exp Med Biol</title>
		<imprint>
			<biblScope unit="volume">602</biblScope>
			<biblScope unit="page" from="69" to="75" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">CD22 regulates B cell receptormediated signals via two domains that independently recruit Grb2 and SHP-1</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Otipoby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Draves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Clark</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="page" from="44315" to="44322" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Paik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kollipara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ji</forename><forename type="middle">H</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Miao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tothova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Horner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Carrasco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gilliland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Chin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Castrillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Depinho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="309" to="323" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">SYK regulates B-cell migration by phosphorylation of the F-actin interacting protein SWAP-70</title>
		<author>
			<persName><forename type="first">G</forename><surname>Pearce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Audzevich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jessberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="1574" to="1584" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">B cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-alpha and Ig-beta</title>
		<author>
			<persName><forename type="first">R</forename><surname>Pelanda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Braun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hobeika</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Nussenzweig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="865" to="872" />
			<date type="published" when="2002">2002a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Cre recombinase-controlled expression of the mb-1 allele</title>
		<author>
			<persName><forename type="first">R</forename><surname>Pelanda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hobeika</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kurokawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kuppig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genesis</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="154" to="157" />
			<date type="published" when="2002">2002b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tussiwand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bosco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Rolink</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">e5456</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Antigen receptor tail clue</title>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">338</biblScope>
			<biblScope unit="page" from="383" to="384" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Signaling circuits in early B-cell development</title>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nielsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Immunol</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="129" to="175" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Structure and function of Syk protein-tyrosine kinase</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yanagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yamamura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biochem</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="177" to="186" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development</title>
		<author>
			<persName><forename type="first">K</forename><surname>Saijo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schmedt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Karasuyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Lowell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Adachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Patke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Santana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarakhovsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="274" to="279" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">TNF family member B cell-activating factor (BAFF) receptor-dependent andindependent roles for BAFF in B cell physiology</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Casola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Kutok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rajewsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schmidt-Supprian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page" from="2245" to="2252" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion</title>
		<author>
			<persName><forename type="first">E</forename><surname>Schweighoffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Vanes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mathiot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Tybulewicz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="523" to="533" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">The BAFF receptor transduces survival signals by coopting the B cell receptor signaling pathway</title>
		<author>
			<persName><forename type="first">E</forename><surname>Schweighoffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Vanes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cantrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mccleary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Smithers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Tybulewicz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="475" to="488" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Multiple regulatory mechanisms control B-1 B cell activation</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Sindhava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bondada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Immunol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">372</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">kinase signals BCRdependent mature B cell survival</title>
		<author>
			<persName><forename type="first">L</forename><surname>Srinivasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Calado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Paik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Depinho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Kutok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Kearney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Otipoby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rajewsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="573" to="586" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca 2+ mobilization through distinct pathways</title>
		<author>
			<persName><forename type="first">M</forename><surname>Takata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Inazu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Homma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nukada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yamamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kurosaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1341" to="1349" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool</title>
		<author>
			<persName><forename type="first">M</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gulbranson-Judge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Walters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Maclennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Tybulewicz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="2013" to="2021" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Evidence for a preformed transducer complex organized by the B cell antigen receptor</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wienands</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Larbolette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="7865" to="7870" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Beavitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Harder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Hibbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Tarlinton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="6910" to="6918" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Lyn tyrosine kinase: accentuating the positive and the negative</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Harder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Huntington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Hibbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Tarlinton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="9" to="18" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">The dissociation activation model of B cell antigen receptor triggering</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">584</biblScope>
			<biblScope unit="page" from="4872" to="4877" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Studying Epstein-Barr virus pathologies and immune surveillance by reconstructing EBV infection in mice</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yasuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wirtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wunderlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schmidt-Supprian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sommermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rajewsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cold Spring Harb Symp Quant Biol</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="259" to="263" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes</title>
		<author>
			<persName><forename type="first">N</forename><surname>Yazawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miyake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Asano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nagai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Okochi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Akira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Tedder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tamaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="1374" to="1380" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">The Authors The EMBO Journal</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">7</biblScope>
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
